Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.6930
+0.0131 (1.93%)
At close: Jul 1, 2025, 4:00 PM
0.6820
-0.0110 (-1.59%)
After-hours: Jul 1, 2025, 7:32 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $35.89 million as of July 1, 2025. Its market cap has decreased by -8.28% in one year.
Market Cap
35.89M
Enterprise Value
-46.51M
1-Year Change
-8.28%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $35.89M, a decrease of -91.59%. That is a compound annual growth rate of -48.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 35.21M | -19.36% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |